1. Home
  2. Journals

Global Journal of Urology and Nephrology

Global Journal of Urology and Nephrology, Recent Articles

Correlation Between Anthropometric Parameters And Biochemical Markers Of Cardiovascular Risk In Chronic Renal Patients On Hemodialysis

Research Article of Global Journal of Urology and Nephrology Correlation Between Anthropometric Parameters And Biochemical Markers Of Cardiovascular Risk In Chronic Renal Patients On Hemodialysis Hannah Fernandes Cavalcanti Brandão1 *, Halanna Celina Magalhães Melo 1,2, Ellen Diana Silva de Souza3, Bruno Soares de Souza1,4, Marilía Tokiko Oliveira Tomiya1,5 Faculdade Pernambucana de Saúde1 e Instituto de Medicina Integral Professor Fernando Figueira2,3,4,5 Objective: To correlate anthropometric parameters and biochemical markers of cardiovascular risk in chronic renal patients undergoing hemodialysis. Methods: Cross-sectional observational study, carried out at the Instituto de Medicina Integral Professor Fernando Figueira - Imip (Recife-PE), from July to October 2018.  Anthropometric parameters were analyzed: The anthropometric measurements used were waist circumference (WC) and waist-height ratio (WHT), sociodemographic data (sex and base disease) and biochemical parameters (HDL, LDL, Total Cholesterol, Triglycerides, Vitamin D, phosphorus, calcium, potassium and parathyroid hormone). Results: Fifty-nine patients with CKD were evaluated in a regular HD program. and males (54.2%). The majority of the population had an undetermined disease (44.1%). Regarding anthropometry, it was observed that there was a predominance in the change in waist circumference (57.6%) and waist/height ratio (59.3%). Regarding the biochemical profile, through pearson’s correlation, it was observed that there was a significant positive association of WC and WHT with phosphorus (ρ*=0.305 and 0.329). In the correlation of WC and WHT with vitamin D, it was seen that as these anthropometric indices increase, vitamin D decreases, making this correlation significant (ρ*=-0.435 and -0.368). Conclusion: It can be concluded that most patients presented inadequate nutritional status, as well as decreased serum vitamin D levels and changes in serum phosphorus levels. These changes may result in increased risk for cardiovascular events in this population. Keywords: Chronic Renal Failure, Nutritional Status, Nutritional Assessment, Cardiovascular Diseases ...
Global Journal of Urology and Nephrology, Recent Articles

Ultrafiltration (UF) Effectiveness on intradialytic hypertension (IDH) in chronic hemodialysed patients in a nephrology unit in Dakar: UF-IDH clinical trial

Research Article of Global Journal of Urology and Nephrology Ultrafiltration (UF) Effectiveness on intradialytic hypertension (IDH) in chronic hemodialysed patients in a nephrology unit in Dakar: UF-IDH clinical trial Ba Bacary 1, Faye Moustapha 1, Keita Niakhaleen 1, Lemrabott Ahmed Tall 1, Seck Sidy Mohamed 2, Faye Maria 1, Mbengue Mansour 1, Diagne Seynabou 1, Ba Mamadou Aw 1, Dieng Ahmed 1, Kane yaya 3, Diouf Boucar 1, Niang Abdou 1, Ka Elhadji Fary 1 1Department of Nephrology, Dialysis and Renal Transplantation of Aristide Le Dantec University Hospital, Cheikh Anta Diop University, Dakar, Senegal. 2Department of nephrology and dialysis of the Military Hospital of Ouakam, Gaston Berger University of Saint Louis, Senegal. 3Departement of nephrology and dialysis of the regional hospital of Ziguichor, Assane Seck university of Ziguinchor, Senegal. Introduction Progressive ultrafiltration (UF) could improve IDH. The aim of this work was to evaluate the effectiveness of progressive UF in the management of IDH. Methods This randomized clinical trial in two groups: interventional group A (UF, n = 12) and control group B (n = 12), was conducted in chronic hemodialysis patients with IDH. A first phase of cross-sectional collection of BP before and after dialysis, during 2 weeks, made it possible to obtain this cohort of 24 patients. A progressive decrease in basal weight of 0.25 kg per session as a function of hemodynamic tolerance was achieved in group A. The primary endpoint, the proportion of patients with disappearance of IDH, was assessed at baseline end of the 4th and 8th week. Results At the 4th week, the IDH disappeared in 83.3% and 41.7% of the patients of the group A and B respectively with a hazard ratio (HR) at 0.29; IC 95 = [0.14-0.59]; p = 0.035. At the 8th week, the IDH was missing in 72.7% and ...
Global Journal of Urology and Nephrology, Recent Articles

Intrinsic factors affecting incidence of urolithiasis in diabetic patients –A preliminary case-control study

Research Article of Global Journal of Urology and Nephrology Intrinsic factors affecting incidence of urolithiasis in diabetic patients –A preliminary case-control study Kalpesh Saswade1, Maria Tom2, Lekshmi Hareendran2, Vishnu Kamalasanan2, Ganesh Sonawane1, Rohan Kumar1, Praveen Singh1, Biju S Pillai3, Krishna Moorthy H4 1Resident, Department of urology, Lourdes Hospital, Kochi, Kerala, India; 2Department of Pharmacy Practice, St. Joseph’s college of pharmacy, Cherthala, Kerala,India; 3 Consultant, Department of urology, Lourdes Hospital, Kochi, Kerala, India; 4Senior Consultant and Head,  Department of urology, Lourdes Hospital, Kochi, Kerala, India There has been a steep rise in incidence of urolithiasis in recent years. Recent studies have revealed an increased prevalence of urolithiasis in patients with Diabetes Mellitus (DM). The role of various intrinsic factors of diabetic patients such as Body Mass Index (BMI), level of glycemic control, baseline kidney function and mode of treatment of DM which can influence incidence of urolithiasis still remains uninvestigated. This case control study was taken up to evaluate these intrinsic factors affecting the incidence of urolithiasis in patients with DM. The case group included diabetic patients with urolithiasis and the control group included age matched diabetic patients without urolithiasis. We concluded that Higher BMI and higher serum creatinine level in diabetic patients were associated with increased incidence of urolithiasis whereas other intrinsic factors such as age, sex, duration of DM and the level of glycemic control did not have any influence on it. Keywords: Diabetes mellitus, Urolithiasis, BMI, Intrinsic factors ...
Global Journal of Urology and Nephrology, Recent Articles

Accuracy of Prostate Specific Antigen Density in Predicting Prostate Cancer- A single-centre UK experience

Research Article of Global Journal of Urology and Nephrology Accuracy of Prostate Specific Antigen Density in Predicting Prostate Cancer- A single-centre UK experience Rahul Pandya#, Ayesha Butt#, Andrei Bancu, S I Miakhil Urology, North West Anglia NHS trust   # Co-lead author Introduction and objectives: PSA has been a useful tool in identifying prostate cancer since its discovery. However relying on this alone can lead to unnecessary over investigation as it can be falsely raised in other conditions. PSA density is a possible enhanced marker for prostate biopsy indication, however it is not standard practice or recommended in national guidelines. Previous studies have shown that PSA density is most useful when the PSA is in the range of 4-10. We aim to study the effectiveness of PSA density at detecting prostate cancer within that range as well as outside that range. Methods: Retrospective single centre study at Peterborough City Hospital including 500 patients who had a MRI prior to prostate biopsy between July 2017 to July 2018. Patients undergoing repeat biopsy already on a cancer pathway were excluded. PSA density was calculated by dividing PSA from the prostate volume recorded on the MRI. A cut of value of PSA density was chosen at 0.15 and 0.10. Results: Data from 500 patients with a mean age of 65 and mean PSA of 10.7 (PSA range 0.32 to 99). 251 (50.2%) patients had cancer on histology with 152 having clinically significant cancer. Mean PSA density was 0.11ng/ml/cm3 with benign histology, 0.36ng/ml/cm3 for all cancer and 0.48ng/ml/cm3 for clinically significant cancer. Overall the mean PSA density in prostate cancer was found to be 0.15. Sensitivity of PSAD at detecting all prostate cancer at cutoff of 0.10 with PSA 4-10 was 76% and 88% for clinically significant prostate cancer (Gleason 7>). The negative predictive value ...

Manuscript Title: The title should be a brief phrase.

Author Information: List full names and affiliation of all authors, including Emails and phone numbers of corresponding author.

Abstract: The abstract should be less than 500 words. Following abstract, a list of keywords and abbreviations should be added. The keywords should be no more than 10. Abbreviation are only used for non standard and long terms.

Introduction: The introduction should included a clear statement of current problems.

Materials and Methods: This section should be clearly described.

Results and discussion: Authors may put results and discussion into a single section or show them separately.

Acknowledgement: This section includes a brief acknowledgment of people, grant details, funds

References: References should be listed in a numbered citation order at the end of the manuscript. DOIs and links to referenced articles should be added if available. Abstracts and talks for conferences or papers not yet accepted should not be cited.

Tables and figures: Tables should be used at a minimum with a short descriptive title. The preferred file formats for Figures/Graphics are GIF, TIFF, JPEG or PowerPoint.

Publication fees: We do not charge any submission charges, but authors are required to pay publication fees after their manuscripts are accepted for publication. For authors who receive our invitations, please send us the invitation code.

Proofreading and Publication: A proof will be sent to the corresponding author. Authors should carefully read it to avoid any errors and return any comments. We will update and publish it shortly. One of our goals is to minimize our publication time. For authors who do not return comments of proofreading on time, we may put the proof onlinefirst and replace it later with the final version. 

Withdrawal Policy: When you want to withdraw a published article, please send us your written request by email. We will withdraw/retract it from our system after reviewing the request. Please allow us enough time to process it. 

Terms of Use/Privacy Policy/Disclaimer/Other Policies: you agree that by using or receiving our services, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies(Click here for details).

About the journal
The journal is hosted by eSciPub LLC. Our aim is to provide a platform that encourages publication of the most recent research and reviews for authors from all countries.

About the publisher
eSciPub LLC is a publisher to support Open Access initiative located in Houston, Texas, USA. It is a member of the largest community of professional publishers in the United States: the Independent Book Publishers Association. It hosts more than 100 Open Access journals in Medicine, Business & Economics, Agriculture, Biological Sciences, Chemistry, Education, Physical Sciences, Sociology, and Engineering and Technology.

Rapid Response Team
Please feel free to contact our rapid response team if you have any questions. Our customer representative will answer your questions shortly.

Global Journal of Urology and Nephrology

 

Loading